Nutex Health (NASDAQ:NUTX – Get Free Report) had its price objective upped by equities research analysts at Maxim Group from $75.00 to $100.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. Maxim Group’s price target indicates a potential downside of 3.65% from the stock’s previous close.
Nutex Health Price Performance
Shares of NUTX opened at $103.79 on Tuesday. Nutex Health has a fifty-two week low of $4.16 and a fifty-two week high of $106.53. The firm’s 50 day moving average price is $59.64 and its 200 day moving average price is $40.47. The company has a market cap of $573.75 million, a P/E ratio of -11.06 and a beta of 0.27. The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36.
Nutex Health (NASDAQ:NUTX – Get Free Report) last announced its quarterly earnings data on Monday, March 31st. The company reported $11.12 EPS for the quarter, beating analysts’ consensus estimates of ($0.09) by $11.21. Nutex Health had a negative net margin of 14.09% and a negative return on equity of 51.27%. The company had revenue of $81.30 million for the quarter, compared to the consensus estimate of $81.13 million.
Institutional Trading of Nutex Health
Nutex Health Company Profile
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
See Also
- Five stocks we like better than Nutex Health
- 3 Best Fintech Stocks for a Portfolio Boost
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- Investing In Automotive Stocks
- Are Tariffs Threatening Disney’s Comeback Story?
- Most active stocks: Dollar volume vs share volume
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.